[go: up one dir, main page]

NO20006581L - Membran eller matriks for å regulere permeeringshastigheten for medikamenter - Google Patents

Membran eller matriks for å regulere permeeringshastigheten for medikamenter

Info

Publication number
NO20006581L
NO20006581L NO20006581A NO20006581A NO20006581L NO 20006581 L NO20006581 L NO 20006581L NO 20006581 A NO20006581 A NO 20006581A NO 20006581 A NO20006581 A NO 20006581A NO 20006581 L NO20006581 L NO 20006581L
Authority
NO
Norway
Prior art keywords
matrix
membrane
elastomeric material
diaphragm
drugs
Prior art date
Application number
NO20006581A
Other languages
English (en)
Other versions
NO20006581D0 (no
NO327955B1 (no
Inventor
Harri Jukarainen
Tommi Markkula
Juha Ala-Sorvari
Matti Lehtinen
Jarkko Ruohonen
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Publication of NO20006581D0 publication Critical patent/NO20006581D0/no
Publication of NO20006581L publication Critical patent/NO20006581L/no
Publication of NO327955B1 publication Critical patent/NO327955B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L83/00—Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon only; Compositions of derivatives of such polymers
    • C08L83/10—Block- or graft-copolymers containing polysiloxane sequences
    • C08L83/12—Block- or graft-copolymers containing polysiloxane sequences containing polyether sequences
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Polymers & Plastics (AREA)
  • Silicon Polymers (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Materials For Medical Uses (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Wrappers (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)

Abstract

Membran eller matriks for å regulere permeerings-hastigheten av et medikament, hvor membranen eller matriksen omfatter et siloksan-basert elastomermateri-ale som omfatter minst én elastomer og eventuelt en ikke-tverrbundet polymer. Elastomermaterialet omfatter polyalkylenoksid-grupper som er til stede i elastomeren eller polymeren som alkoksy-terminerte påpodede polysiloksan-enheter eller blokker som er bundet til polysiloksan-enhetene med silisium-karbon-bindinger, eller som en blanding av disse former. Det beskrives også fremgangsmåter for fremstilling av elastomermaterialet anvendt i membranen eller matriksen.
NO20006581A 1998-06-30 2000-12-21 Membran eller matriks for a regulere permeeringshastigheten for medikamenter NO327955B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI981506A FI107339B (fi) 1998-06-30 1998-06-30 Lääkeaineiden läpäisynopeutta säätävä kalvo tai matriisi
PCT/FI1999/000511 WO2000000550A1 (en) 1998-06-30 1999-06-11 A membrane or matrix for controlling the permeation rate of drugs

Publications (3)

Publication Number Publication Date
NO20006581D0 NO20006581D0 (no) 2000-12-21
NO20006581L true NO20006581L (no) 2000-12-29
NO327955B1 NO327955B1 (no) 2009-10-26

Family

ID=8552104

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006581A NO327955B1 (no) 1998-06-30 2000-12-21 Membran eller matriks for a regulere permeeringshastigheten for medikamenter

Country Status (29)

Country Link
EP (1) EP1124902B1 (no)
JP (1) JP2002519467A (no)
KR (1) KR100599868B1 (no)
CN (2) CN1269909C (no)
AR (1) AR018952A1 (no)
AT (1) ATE290049T1 (no)
AU (1) AU752895B2 (no)
BG (1) BG65148B1 (no)
BR (1) BR9911140B1 (no)
CA (1) CA2336149C (no)
CO (1) CO5060523A1 (no)
CZ (1) CZ299613B6 (no)
DE (1) DE69923992T2 (no)
EE (1) EE04685B1 (no)
ES (1) ES2237120T3 (no)
FI (1) FI107339B (no)
HK (1) HK1038939A1 (no)
HU (1) HU229159B1 (no)
NO (1) NO327955B1 (no)
NZ (1) NZ508275A (no)
PE (1) PE20000935A1 (no)
PL (1) PL193485B1 (no)
PT (1) PT1124902E (no)
RU (1) RU2201794C2 (no)
SK (1) SK285325B6 (no)
TW (1) TWI237571B (no)
UA (1) UA71566C2 (no)
WO (1) WO2000000550A1 (no)
ZA (1) ZA200006986B (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6476079B1 (en) 1999-12-23 2002-11-05 Leiras Oy Devices for the delivery of drugs having antiprogestinic properties
AU2002210580A1 (en) * 2000-10-20 2002-04-29 Leiras Oy Drug delivery system
EP1438942A1 (en) * 2003-01-17 2004-07-21 Schering Oy An otorhinological drug delivery device
DE602005005506T2 (de) * 2004-08-25 2009-04-23 Union Carbide Chemicals & Plastics Technology Corp., Danbury Polymerfolie
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
PL2118174T3 (pl) 2007-03-12 2013-04-30 Bayer Oy Zastosowanie tokoferolu
EP2140860A1 (en) 2008-07-03 2010-01-06 Bayer Schering Pharma Oy An improved method of contraception
FI20080523A0 (fi) 2008-09-17 2008-09-17 Bayer Schering Pharma Oy Insertteri
BRPI0919071B1 (pt) 2008-09-17 2019-09-03 Bayer Oy dispositivo para inserção
US11992431B2 (en) 2008-09-17 2024-05-28 Bayer Oy Inserter
FI20080524A0 (fi) 2008-09-17 2008-09-17 Bayer Schering Pharma Oy Insertteri
FI122579B (fi) 2010-10-29 2012-03-30 Bayer Oy Insertteri
CN102008909B (zh) * 2010-12-13 2012-10-10 大连欧科膜技术工程有限公司 一种气体分离复合膜的制备方法
CN102068914B (zh) * 2010-12-13 2012-10-10 大连欧科膜技术工程有限公司 一种气体分离复合膜的制备方法
CA2871001A1 (en) 2012-04-23 2013-10-31 Bayer Pharma Aktiengesellschaft Application of 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one systems in the treatment of menorrhagia, as well as intrauterine systems containing 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one for treating uterine bleeding disorders
TW201350122A (zh) 2012-04-23 2013-12-16 Bayer Pharma AG １８－甲基－１５β，１６β－亞甲基－１９－降－２０－螺氧－４－烯－３－酮的子宮內用途，包含１８－甲基－１５β，１６β－亞甲基－１９－降－２０－螺氧－４－烯－３－酮的子宮內系統，及其於避孕及婦科治療之用途
EP3057573A1 (en) * 2013-10-18 2016-08-24 Bayer Oy Intrauterine delivery system
EP3294300B1 (en) 2015-05-13 2024-12-18 Bayer Oy Long acting drug delivery device in form of an implant or iud comprising levonorgestrel and ethinylestradiol
WO2018202574A1 (en) 2017-05-04 2018-11-08 Bayer Oy Intravaginal drug delivery system, method for manufacturing such system and its use in gynecological therapies and contraception
AU2018390990B2 (en) 2017-12-22 2024-10-31 Alyra Biotech Pty Ltd Treatment of pain and/or pain related symptoms associated with dysmenorrhea
ES2834450T3 (es) 2018-03-05 2021-06-17 Evonik Operations Gmbh Copolímeros en bloques de poliéter-siloxano reticulados, así como su empleo para la producción de espumas de poliuretano

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5889108A (en) * 1997-06-02 1999-03-30 Dow Corning Corporation Thickening solvents with elastomeric silicone polyethers

Also Published As

Publication number Publication date
ZA200006986B (en) 2001-05-23
FI981506L (fi) 1999-12-31
HUP0102600A3 (en) 2004-04-28
CN1176999C (zh) 2004-11-24
KR20010053346A (ko) 2001-06-25
EP1124902B1 (en) 2005-03-02
UA71566C2 (uk) 2004-12-15
CN1269909C (zh) 2006-08-16
AU4783999A (en) 2000-01-17
PL345103A1 (en) 2001-12-03
AR018952A1 (es) 2001-12-12
RU2201794C2 (ru) 2003-04-10
CA2336149C (en) 2007-01-02
FI107339B (fi) 2001-07-13
BR9911140B1 (pt) 2009-08-11
BR9911140A (pt) 2001-03-06
HUP0102600A2 (hu) 2001-11-28
EE200000788A (et) 2002-04-15
PL193485B1 (pl) 2007-02-28
NZ508275A (en) 2002-09-27
CN1308653A (zh) 2001-08-15
JP2002519467A (ja) 2002-07-02
EE04685B1 (et) 2006-08-15
WO2000000550A1 (en) 2000-01-06
ES2237120T3 (es) 2005-07-16
CN1488678A (zh) 2004-04-14
NO20006581D0 (no) 2000-12-21
AU752895B2 (en) 2002-10-03
BG105081A (en) 2001-09-28
ATE290049T1 (de) 2005-03-15
DE69923992D1 (de) 2005-04-07
TWI237571B (en) 2005-08-11
BG65148B1 (bg) 2007-04-30
HU229159B1 (hu) 2013-09-30
CZ20004749A3 (cs) 2001-10-17
FI981506A0 (fi) 1998-06-30
SK285325B6 (sk) 2006-11-03
PE20000935A1 (es) 2000-09-18
EP1124902A1 (en) 2001-08-22
CA2336149A1 (en) 2000-01-06
NO327955B1 (no) 2009-10-26
DE69923992T2 (de) 2006-04-13
PT1124902E (pt) 2005-07-29
SK18942000A3 (sk) 2001-07-10
KR100599868B1 (ko) 2006-07-12
CO5060523A1 (es) 2001-07-30
CZ299613B6 (cs) 2008-09-17
HK1038939A1 (en) 2002-04-04

Similar Documents

Publication Publication Date Title
NO20006581L (no) Membran eller matriks for å regulere permeeringshastigheten for medikamenter
ATE45970T1 (de) Haertbare chemische zusammensetzung und damit hergestellte mehrschichtige semipermeable membranen.
CA2395226A1 (en) Devices for the delivery of drugs having antiprogestinic properties
NO20053849L (no) Otorhinologisk avleveringsinnretning
ATE92362T1 (de) Mikroporoese asymmetrische polyfluorkohlenstoffmembrane.
AU4613097A (en) Microporous membranes and uses thereof
AU2003262175A1 (en) Hydrophilic adhesive compositions__________________________
NO931809D0 (no) Hemofilter
DE60329390D1 (de) Blasenschutz für spiralförmig gewickelte elemente
BR0108711A (pt) Expressão heteróloga de proteìnas de neisseria
AU2003248330A1 (en) Ceramic membrane based on a substrate containing polymer or natural fibres, method for the production and use thereof
NO941381D0 (no) Colostrumfraksjon, fremgangsmåte for fremstilling og anvendelse av denne som et cellekulturmediumsupplement
WO2002027846A3 (en) Method and apparatus for improved fluid flow within an electrochemical cell
BRPI0517514A (pt) vesìculas bacterianas imunogênicas com proteìnas da membrana externa
HUP0104380A2 (hu) Gyógyszerhatóanyag áthatolását szabályozó membrán vagy mátrix
ES2094056T3 (es) Metodo para la produccion de membranas de fibra hueca ceramica para la microfiltracion, ultrafiltracion y separacion de gases.
DE59913783D1 (de) Mikrosysteme zur zellpermeation und zellfusion
AU2001291941A1 (en) Membranes for selective gas separation
DE69532646D1 (de) Verfahren zur herstellung extrazellulärer proteine in bakterien
DE59404889D1 (de) Gummielastische membran
ATE311424T1 (de) Elastische dichtungsmaterialien auf der basis von blockcopolymeren aus isobuten und vinylaromatischen monomeren
AU2003284174A1 (en) Organosiloxane resin-polyene materials
WO2005058465A3 (en) Pressure driven separations of liquid feeds
BR112023018969A2 (pt) Partículas de nanocompósitos e métodos de fabricação e uso das mesmas
AU2003262176A1 (en) Solid emulsions based on thermoplastic elastomers

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees